Skip to main content

Table 2 Primary outcomes – Antiarrhythmic medications, anticoagulant medications, cardioversions, and catheter ablation

From: Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study

Outcomes

Patients (n = 77,207)

Antiarrhythmic medicationa, n (%)

 

 0

55,077 (71.3)

 1

19,196 (24.9)

 2+

3,934 (3.8)

Anticoagulant medicationb, n (%)

 

 0

41,479 (53.7)

 1

32,239 (41.8)

 2+

3,489 (4.5)

Direct current cardioversion, n (%)

18,875 (24.4)

Catheter ablation, n (%)

5,451 (7.1)

  1. a Anti-arrhythmic medications included: amiodarone, disopyramide, dofetilide, dronedarone, flecainide, quinidine, propafenone, and sotalol
  2. b Anticoagulant medications included: warfarin, apixaban, dabigatran, rivaroxaban, and edoxaban